Literature DB >> 11053714

Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction.

M M Zhu1, J Weedon, L T Clark.   

Abstract

This meta-analysis examined all the published reports up to October 1999 that studied the association between PlA2 polymorphism of platelet glycoprotein IIIa gene and myocardial infarction. The PlA2 polymorphism was not found to be associated with an increased risk of myocardial infarction, either overall or in selected subgroups, which were patients with premature disease onset (age < or = 60 years), first acute myocardial infarction, and patients who were men, women, and exclusively Caucasian.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11053714     DOI： 10.1016/s0002-9149(00)01136-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

Review 2.  The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.

Authors:  Christopher N Floyd; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

Review 3.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.

Authors:  Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

4.  Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample.

Authors:  Lauren A Weiss; Mark Abney; Rodney Parry; Angelo M Scanu; Edwin H Cook; Carole Ober
Journal:  Hum Genet       Date:  2005-04-15       Impact factor: 4.132

5.  Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke.

Authors:  Blanca Elsa Rivera-García; Juan Carlos Esparza-García; Jose Luis Aceves-Chimal; Alfredo Leaños-Miranda; Abraham Majluf-Cruz; Irma Isordia-Salas
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

6.  Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Anna M Kucharska-Newton; Keri L Monda; Stephen Campbell; Patrick T Bradshaw; Lynne E Wagenknecht; Eric Boerwinkle; Bruce A Wasserman; Gerardo Heiss
Journal:  Atherosclerosis       Date:  2011-02-02       Impact factor: 5.162

7.  Platelet glycoprotein IIIA PIA2 polymorphism is associated with ST elevation acute myocardial infarction in young Mexican population.

Authors:  David Santiago-Germán; Alfredo Leaños-Miranda; Ethel García-Latorre; Gabriela Borrayo-Sánchez; Abraham Majluf-Cruz; Irma Isordia-Salas
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

8.  The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events.

Authors:  Gennaro Galasso; Gaetano Santulli; Federico Piscione; Roberta De Rosa; Valentina Trimarco; Raffaele Piccolo; Salvatore Cassese; Guido Iaccarino; Bruno Trimarco; Massimo Chiariello
Journal:  BMC Cardiovasc Disord       Date:  2010-09-16       Impact factor: 2.298

Review 9.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

10.  Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.

Authors:  Joshua W Knowles; Huijan Wang; Haruka Itakura; Audrey Southwick; Richard M Myers; Carlos Iribarren; Stephen P Fortmann; Alan S Go; Thomas Quertermous; Mark A Hlatky
Journal:  Am Heart J       Date:  2007-12       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.